Cancer Research Infection and Cancer: Biology, Therapeutics, and Prevention  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 29, 2034-2038, November 1, 1969]
© 1969 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Walborg, E. F.
Right arrow Articles by Wray, V. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Walborg, E. F., Jr.
Right arrow Articles by Wray, V. P.

Isolation and Chemical Characterization of a Cell-Surface Sialoglycopeptide Fraction from Novikoff Ascites Cells1

Earl F. Walborg, Jr., Roberta S. Lantz and Virginia P. Wray

Biochemistry Department, The University of Texas, M. D. Anderson Hospital and Tumor Institute at Houston, Houston, Texas 77025

Sialic acid has been shown to contribute significantly to the cell-surface charge of tumor cells. In order to elucidate the chemical nature of the sialic acid-containing molecules present on the tumor cell surface, a procedure for the isolation of a sialoglycopeptide fraction from the surface of Novikoff ascites cells has been developed. Digestion of tumor cell suspensions with papain liberates a sialoglycopeptide fraction from the cell surface. This fraction was partially purified using trichloroacetic acid precipitation, dialysis, and gel filtration on Sephadex G-50. The sialoglycopeptide fraction contains 65–80% of the neuraminidase-labile sialic acid present on the surface of these cells. Quantitative analysis of the composition of this fraction revealed the presence of the following monosaccharides, expressed per mg glycopeptide: 0.39 µmole sialic acid, 0.41 µmole glucosamine, 0.23 µmole galactosamine, 0.15 µmole mannose, 0.54 µmole galactose, 0.53 µmole glucose, and 0.15 µmole uronic acid. Amino acid analysis indicated a peptide content of 15%. Amino acids present in the highest amounts were threonine, aspartic acid, glutamic acid, serine, proline, alanine, and valine (molar ratio, 4:2:1.5:1:1:1:1).

1 This research was supported by Research Grant P-451 from the American Cancer Society and USPHS Institutional Grant No. FR 05511-03-5.

Received 3/ 3/69. Accepted 4/17/69.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1969 by the American Association for Cancer Research.